CSIMarket
 


Allovir Inc   (ALVR)
Other Ticker:  
 

Allovir Inc 's Quick Ratio

ALVR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 6.45 a new company low.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Quick Ratio than Allovir Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the III Quarter 2023 to 98, from total ranking in the second quarter 2023 at 310.

Explain Quick Ratio?
How much Cash & cash equivalents ALVR´s has?
What are ALVR´s Current Liabilities?


ALVR Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 59.59 % 41.57 % 33.91 % -35.7 % -14.29 %
Y / Y Cash & cash equivalent Change -19.23 % 42.78 % 0.59 % -5.77 % -4.25 %
Quick Ratio MRQ 6.45 8.07 8.12 9.61 12.75
ALVR's Total Ranking # 98 # 310 # 438 # 43 # 309
Seq. Current Liabilities Change 8.19 % 22.45 % 2.55 % 17.47 % -4.03 %
Seq. Cash & cash equivalent Change -13.47 % 21.7 % -13.36 % -11.48 % 52.95 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 43
Overall Market # 98


Quick Ratio Statistics
High Average Low
28.98 13.38 6.45
(Dec 31 2020)   (Sep 30 2023)




Financial Statements
Allovir Inc 's Current Liabilities $ 33 Millions Visit ALVR's Balance sheet
Allovir Inc 's Cash & cash equivalent $ 213 Millions Visit ALVR's Balance sheet
Source of ALVR's Sales Visit ALVR's Sales by Geography


Cumulative Allovir Inc 's Quick Ratio

ALVR's Quick Ratio for the trailling 12 Months

ALVR Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 59.59 % 41.57 % 33.91 % -35.7 % -14.29 %
Y / Y Cash & cash equivalent TTM Growth -19.23 % 42.78 % 0.59 % -5.77 % -4.25 %
Quick Ratio TTM 7.94 9.42 9.53 10.22 8.97
Total Ranking TTM # 351 # 2188 # 3356 # 68 # 274
Seq. Current Liabilities TTM Growth 8.19 % 22.45 % 2.55 % 17.47 % -4.03 %
Seq. Cash & cash equivalent TTM Growth -13.47 % 21.7 % -13.36 % -11.48 % 52.95 %


On the trailing twelve months basis Due to rise in Current Liabilities in the III Quarter 2023 to $33.07 millions, cumulative Quick Ratio decreased to 7.94 below the Allovir Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 56 other companies have achieved higher Quick Ratio than Allovir Inc . While Quick Ratio overall ranking has improved so far to 351, from total ranking during the twelve months ending second quarter 2023 at 2188.

Explain Quick Ratio?
How much Cash & cash equivalents ALVR´s has?
What are ALVR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 254
Within the Market # 351


trailing twelve months Quick Ratio Statistics
High Average Low
23.42 12.89 7.94
(Mar 31 2021)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
4d Molecular Therapeutics Inc   17.60 $ 319.664  Millions$ 18.163  Millions
Icosavax Inc   17.59 $ 229.206  Millions$ 13.030  Millions
Neumora Therapeutics Inc   17.50 $ 509.565  Millions$ 29.123  Millions
Hillevax Inc   17.11 $ 324.410  Millions$ 18.958  Millions
Fusion Pharmaceuticals Inc   16.92 $ 191.348  Millions$ 11.312  Millions
Crispr Therapeutics Ag  15.64 $ 1,739.826  Millions$ 111.234  Millions
Denali Therapeutics Inc   15.58 $ 1,109.256  Millions$ 71.180  Millions
Cabaletta Bio Inc   15.49 $ 164.391  Millions$ 10.616  Millions
Voyager Therapeutics Inc   14.51 $ 252.936  Millions$ 17.427  Millions
Pharmacyte Biotech Inc   14.01 $ 73.425  Millions$ 5.240  Millions
Iteos Therapeutics Inc   13.82 $ 599.027  Millions$ 43.349  Millions
Caribou Biosciences Inc   13.78 $ 338.488  Millions$ 24.572  Millions
Vor Biopharma Inc   13.75 $ 160.098  Millions$ 11.645  Millions
Aura Biosciences Inc   13.68 $ 149.076  Millions$ 10.894  Millions
Vigil Neuroscience Inc   13.18 $ 133.643  Millions$ 10.142  Millions
Anavex Life Sciences Corp   13.00 $ 151.024  Millions$ 11.617  Millions
Replimune Group Inc   12.47 $ 496.761  Millions$ 39.832  Millions
Elevation Oncology inc   12.46 $ 94.797  Millions$ 7.607  Millions
Allogene Therapeutics inc   12.37 $ 465.505  Millions$ 37.636  Millions
Ambrx Biopharma Inc   12.33 $ 225.262  Millions$ 18.268  Millions
Scholar Rock Holding Corp  11.19 $ 218.635  Millions$ 19.530  Millions
Kymera Therapeutics Inc   11.11 $ 357.825  Millions$ 32.219  Millions
Protara Therapeutics Inc   10.93 $ 74.034  Millions$ 6.775  Millions
Vir Biotechnology Inc   10.29 $ 1,698.921  Millions$ 165.050  Millions
Ikena Oncology Inc   10.22 $ 196.933  Millions$ 19.271  Millions
Inhibrx Inc   9.99 $ 337.327  Millions$ 33.760  Millions
Invivyd Inc   9.89 $ 264.885  Millions$ 26.791  Millions
Cardiff Oncology inc   9.77 $ 81.363  Millions$ 8.330  Millions
Black Diamond Therapeutics Inc   9.57 $ 144.256  Millions$ 15.066  Millions
Solid Biosciences Inc   9.03 $ 142.884  Millions$ 15.816  Millions

Date modified: 2023-11-03T16:32:29+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com